Market cap
$9,045 Mln
Revenue (TTM)
$470 Mln
P/E Ratio
41.5
P/B Ratio
6.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 6.81 | 30.21 | 25.96 | 280.15 | -- |
| EBIT | 21.29 | 67.08 | 31.32 | 139.76 | 44.64 |
| Net Profit | 15.15 | -20.53 | 13.20 | 95.28 | 42.48 |
| EPS | 14.48 | -23.12 | 10.71 | 91.58 | 36.46 |
| Book Value | -- | -- | 28.57 | 25.84 | 22.79 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -35.85 | -35.85 | 52.23 | 48.69 | 35.52 |
| Net Margin
| -- | -- | 47.91 | -- | -- |
| Return on equity
| 10.31 | -1.97 | 16.60 | 18.91 | 10.34 |
| Return on Capital
| 10.22 | -1.88 | -- | 18.77 | 10.25 |
| Return on Assets
| 9.42 | -2.05 | 14.72 | 17.14 | 9.51 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.01 | 0.01 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
18.77
|
10.25
|
1.66
|
-24.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
16.60
Higher than Peers by 56.12
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
16.60
|
18.91
|
10.34
|
1.68
|
-25.09
|
|
Peer Median
|
-39.52
|
--
|
--
|
--
|
--
|
ROA
14.72
Higher than Peers by 45.86
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
14.72
|
17.14
|
9.51
|
1.59
|
-23.63
|
|
Peer Median
|
-31.14
|
--
|
--
|
--
|
--
|
EBIT Margin
52.23
Higher than Peers by 112.26
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
52.23
|
48.69
|
35.52
|
-191.77
|
--
|
|
Peer Median
|
-60.02
|
--
|
--
|
--
|
--
|
Net Margin
47.91
Higher than Peers by 116.78
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
47.91
|
52.64
|
30.69
|
21.56
|
--
|
|
Peer Median
|
-68.87
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
25.96
Lower than Peers by 29.04
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
25.96
|
0.34
|
4.73
|
--
|
--
|
|
Peer Median
|
55.00
|
--
|
--
|
--
|
--
|
EBIT Growth
31.32
Higher than Peers by 32.80
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
31.32
|
83.60
|
206.14
|
19.11
|
-76.56
|
|
Peer Median
|
-1.47
|
--
|
--
|
--
|
--
|
Net Profit Growth
13.20
Higher than Peers by 19.25
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
13.20
|
129.74
|
715.58
|
107.81
|
-101.20
|
|
Peer Median
|
-6.05
|
--
|
--
|
--
|
--
|
EPS Growth
10.71
Lower than Peers by 2.65
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
10.71
|
1.29
|
6.87
|
1.07
|
-0.75
|
|
Peer Median
|
13.36
|
--
|
--
|
--
|
--
|
Book Value Growth
22.05
Higher than Peers by 30.25
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
22.05
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-8.20
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
0.01
|
0.01
|
0.01
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
7.89
Higher than Peers by 2.09
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
7.89
|
9.95
|
7.28
|
17.76
|
13.30
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
7.53
Higher than Peers by 1.88
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
7.53
|
9.56
|
7.02
|
17.55
|
13.30
|
|
Peer Median
|
5.65
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
--
|
--
|
--
|
-23.02
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
28.32
Higher than Peers by 9.45
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
28.32
|
32.75
|
36.06
|
82.92
|
--
|
|
Peer Median
|
18.87
|
--
|
--
|
--
|
--
|
Asset Turnover
0.31
Higher than Peers by 0.24
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
0.31
|
0.33
|
0.31
|
0.07
|
--
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
108.96
|
92.27
|
151.43
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
425.15
|
304.90
|
412.29
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
52.19
|
62.21
|
344.12
|
557.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
481.92
|
334.96
|
219.61
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
41.47
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
41.47
|
36.05
|
52.51
|
327.03
|
-14.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
6.31
Higher than Peers by 2.00
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
6.31
|
6.05
|
4.95
|
4.59
|
3.88
|
|
Peer Median
|
4.31
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
34.82
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
34.82
|
33.49
|
37.22
|
-33.08
|
-14.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
9,045
Higher than Peers by 8,907
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Krystal Biotech (KRYS)
|
9,045
|
--
|
--
|
--
|
--
|
|
Peer Median
|
138
|
--
|
--
|
--
|
--
|